1. Cavalera M, Axling U, Berger K, Holm C. Rose hip supplementation increases energy expenditure and induces browning of white adipose tissue. Nutrition & metabolism. 2016;13:1-9.
2. Pineda E, Sanchez-Romero LM, Brown M, Jaccard A, Jewell J, Galea G, et al. Forecasting future trends in obesity across Europe: the value of improving surveillance. Obesity facts. 2018;11(5):360-71.
3. Taherzadeh S, Rasoulian B, Khaleghi M, Rashidipour M, Mogharnasi M, Kaeidi A. Anti-obesity effects of aerobic exercise along with Rosa canina seed extract supplementation in rats: The role of irisin and adipolin. Obesity Research & Clinical Practice. 2023;17(3):218-25.
4. Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022;55(1):31-55.
5. Nono Nankam PA, Nguelefack TB, Goedecke JH, Blüher M. Contribution of adipose tissue oxidative stress to obesity-associated diabetes risk and ethnic differences: Focus on women of African ancestry. Antioxidants. 2021;10(4):622.
6. Manna P, Jain SK. Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: causes and therapeutic strategies. Metabolic syndrome and related disorders. 2015;13(10):423-44.
7. Jovanović M, Kovačević S, Brkljačić J, Djordjevic A. Oxidative stress linking obesity and cancer: is obesity a 'Radical trigger'to Cancer?. International Journal of Molecular Sciences. 2023;24(9):8452.
8. Panic A, Stanimirovic J, Sudar-Milovanovic E, Isenovic ER. Oxidative stress in obesity and insulin resistance. Exploration of Medicine. 2022;3(1):58-70.
9. Gong J, Tu W, Liu J, Tian D. Hepatocytes: A key role in liver inflammation. Frontiers in immunology. 2023;13:1083780.
10. Arjun Kalra EY, Chase J. Wehrle, Faiz Tuma. Physiology, Liver: StatPearls Publishing; 2023.
11. Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. Journal of hepatology. 2023;79(2):516-37.
12. Jepsen P, Younossi ZM. The global burden of cirrhosis: a review of disability-adjusted life-years lost and unmet needs. Journal of Hepatology. 2021;75:S3-13.
13. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51(2):679-89.
14. Salmasi Fard AH, Azarbayjani MA. The effect of aerobic exercise on JAK/STAT signaling pathway. Journal of Sports Physiology and Athletic Conditioning. 2024;13(13):52.
15. SalmasiFard AH, Azarbayjani MA, Riazi-Rad F, peeri m, Matin-Homaee H. The impact of aerobic exercise and Iranian ethanolic extract of bitter orange peel on PGC-1α gene expression in the liver tissue of obese female Wistar rats. Physical Activity and Health. 2024;3(3).(in Persian)
16. Sun EJ, Wankell M, Palamuthusingam P, McFarlane C, Hebbard L. Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma. Biomedicines. 2021;9(11):1639.
17. Sun HJ, Jiao B, Wang Y, Zhang YH, Chen G, Wang ZX, et al. Necroptosis contributes to non-alcoholic fatty liver disease pathoetiology with promising diagnostic and therapeutic functions. World Journal of Gastroenterology. 2024;30(14):1968.
18. Chettouh H, Lequoy M, Fartoux L, Vigouroux C, Desbois‐Mouthon C. Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma. Liver International. 2015;35(10):2203-17.
19. Shi T, Kobara H, Oura K, Masaki T. Mechanisms underlying hepatocellular carcinoma progression in patients with type 2 diabetes. Journal of Hepatocellular Carcinoma. 2021:45-55.
20. Marchesini G, Moscatiello S, Di Domizio S, Forlani G. Obesity-associated liver disease. The Journal of Clinical Endocrinology & Metabolism. 2008;93(11-supplement-1):s74-80.
21. Sumida Y, Niki E, Naito Y, Yoshikawa T. Involvement of free radicals and oxidative stress in NAFLD/NASH. Free radical research. 2013;47(11):869-80.
22. Koek GH, Liedorp PR, Bast A. The role of oxidative stress in non-alcoholic steatohepatitis. Clinica chimica acta. 2011;412(15-16):1297-305.
23. Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free radical biology and medicine. 2012;52(1):59-69.
24. O'neill HM. AMPK and exercise: glucose uptake and insulin sensitivity. Diabetes & metabolism journal. 2013;37(1):1.
25. Babaei P, Hoseini R. Exercise training modulates adipokine dysregulations in metabolic syndrome. Sports Medicine and Health Science. 2022;4(1):18-28.
26. Wen X, Zhang B, Wu B, Xiao H, Li Z, Li R, et al. Signaling pathways in obesity: mechanisms and therapeutic interventions. Signal transduction and targeted therapy. 2022;7(1):298. [
DOI:10.1038/s41392-022-01188-4]
27. Martínez‐Montoro JI, Benítez‐Porres J, Tinahones FJ, Ortega‐Gómez A, Murri M. Effects of exercise timing on metabolic health. Obesity Reviews. 2023;24(10):e13599.
28. El-Shiekh RA, Al-Mahdy DA, Hifnawy MS, Abdel-Sattar EA. In-vitro screening of selected traditional medicinal plants for their anti-obesity and anti-oxidant activities. South African journal of botany. 2019;123:43-50.
29. Abdelbasset WK, Tantawy SA, Kamel DM, Alqahtani BA, Soliman GS. A randomized controlled trial on the effectiveness of 8-week high-intensity interval exercise on intrahepatic triglycerides, visceral lipids, and health-related quality of life in diabetic obese patients with nonalcoholic fatty liver disease. Medicine. 2019;98(12):e14918.
30. Petridou A, Siopi A, Mougios V. Exercise in the management of obesity. Metabolism. 2019;92:163-9.
31. Mohammad M, Karim D, Mehdi M, Marziyeh S, Hadi S, Shila N. The combinatory effect of spirulina supplementation and resistance exercise on plasma contents of adipolin, apelin, ghrelin, and glucose in overweight and obese men. Mediators of Inflammation. 2022;2022(1):9539286.
32. Abdi A, Mehrabani J, Nordvall M, Wong A, Fallah A, Bagheri R. Effects of concurrent training on irisin and fibronectin type-III domain containing 5 (FNDC5) expression in visceral adipose tissue in type-2 diabetic rats. Archives of physiology and biochemistry. 2022;128(3):651-6.
33. Keating SE, Hackett DA, Parker HM, O'Connor HT, Gerofi JA, Sainsbury A, et al. Effect of aerobic exercise training dose on liver fat and visceral adiposity. Journal of hepatology. 2015;63(1):174-82.
34. Slentz CA, Bateman LA, Willis LH, Shields AT, Tanner CJ, Piner LW, et al. Effects of aerobic vs. resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT/RT. American Journal of Physiology-Endocrinology and Metabolism. 2011;301(5):E1033-9.
35. de Piano A, de Mello MT, Sanches PD, da Silva PL, Campos RM, Carnier J, et al. Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents. European journal of gastroenterology & hepatology. 2012;24(11):1313-24.
36. Orci LA, Gariani K, Oldani G, Delaune V, Morel P, Toso C. Exercise-based interventions for nonalcoholic fatty liver disease: a meta-analysis and meta-regression. Clinical gastroenterology and hepatology. 2016;14(10):1398-411.
37. Shokati P, Fatolahi H. The effect of six weeks of aerobic exercise with pomegranate peel extract on liver enzymes of obese female rats. Journal of Torbat Heydariyeh University of Medical Sciences. 2022;10(2):13-24.(in Persian)
38. Xiao CL, Zhong ZP, Lü C, Guo BJ, Chen JJ, Zhao T, et al. Physical exercise suppresses hepatocellular carcinoma progression by alleviating hypoxia and attenuating cancer stemness through the Akt/GSK-3β/β-catenin pathway. Journal of Integrative Medicine. 2023;21(2):184-93.
39. Zhang X, Xia Y, Cao L, Ji B, Ge Z, Zheng Q, et al. PC 18: 1/18: 1 mediates the anti-inflammatory effects of exercise and remodels tumor microenvironment of hepatocellular carcinoma. Life Sciences. 2024;336:122335.
40. Chen L, Ren T, Tan Y, Li H. Global trends of research on depression in breast cancer: A bibliometric study based on VOSviewer. Frontiers in psychology. 2022;13:969679.
41. Fresno-Alba S, Denche-Zamorano Á, Pastor-Cisneros R, Pereira-Payo D, Franco-García JM, Jiménez-Castuera R. Breast cancer and physical activity: A bibliometric analysis. Frontiers in oncology. 2023;12:1051482.
42. Moosavi-Sohroforouzani A, Ganbarzadeh M. Reviewing the physiological effects of aerobic and resistance training on insulin resistance and some biomarkers in non-alcoholic fatty liver disease. Feyz Medical Sciences Journal. 2016;20(3):282-96.(in Persian)
43. Chen Z, Zhou R, Liu X, Wang J, Wang L, Lv Y, et al. Effects of Aerobic Exercise on Blood Lipids in People with Overweight or Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Life. 2025;15(2):166.
44. Rafie R, Hosseini SA, Hajiani E, Saki Malehi A, Mard SA. Effect of ginger powder supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial. Clinical and experimental gastroenterology. 2020;13:35-45.
45. Hejazi K, Hackett D. Effect of exercise on liver function and insulin resistance markers in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. Journal of clinical medicine. 2023;12(8):3011.
46. Hematinezhad TM, Elmieh A, Hosseinpour A. The Effect of Six-Week Aerobic Exercise Combined with max Increase 2 Green Tea Consumption on PON1 and VO and Apelin, Blood Pressure, and Blood Lipids Reduction in Young Obese Men.Archives of Razavi Institute.2022;77(6):2115-2123.
47. Sini, Z.K., Afzalpour, M.E., Ahmadi, M.M., Sardar, M.A., Khaleghzadeh, H., Gorgani-Firuzjaee, S., et al. Comparison of the effects of high-intensity interval training and moderate-intensity continuous training on indices of liver and muscle tissue in high-fat diet-induced male rats with non-alcoholic fatty liver disease. Egyptian Liver Journal.2022;12(1):63.
48. Charatcharoenwitthaya P, Kuljiratitikal K, Aksornchanya O, Chaiyasoot K, Bandidniyamanon W, Charatcharoenwitthaya N. Moderate-intensity aerobic vs resistance exercise and dietary modification in patients with nonalcoholic fatty liver disease: a randomized clinical trial. Clinical and Translational Gastroenterology. 2021;12(3):e00316.
49. Sahraei M, Abdi A, Jalal H. Protective effect of berberine chloride and aerobic training on liver Nrf2/HO-1 pathway and PPARγ in streptozotocin-induced diabetic rats. Journal of Ardabil University of Medical Sciences. 2020;20(3):296-306.(in Persian)
50. Keating SE, Sabag A, Hallsworth K, Hickman IJ, Macdonald GA, Stine JG, George J, Johnson NA. Exercise in the management of metabolic-associated fatty liver disease (MAFLD) in adults: A position statement from exercise and sport science Australia. Sports Medicine. 2023;53(12):2347-71.
51. Xue Y, Peng Y, Zhang L, Ba Y, Jin G, Liu G. Effect of different exercise modalities on nonalcoholic fatty liver disease: a systematic review and network meta-analysis. Scientific reports. 2024;14(1):6212.
52. Norouzpour M, Marandi M, Ghanbarzadeh M, ZareMaivan A. The effect of aerobic-resistance exercise on serum level of retinol-bonded protein 4, abdominal obesity, and metabolic markers in postmenopausal women with non-alcoholic fatty liver. Journal of Applied Exercise Physiology. 2020;16(32):171-86.(in Persian)
53. Zandi B, Abedi B. Effects of Aerobic Training with Ginger Consumption on Plasma Levels of Adipokine Glipican-4 and Hepatokine Fetuin-A in Rats with Non-alcoholic Fatty Livers. Iranian Journal of Nutrition Sciences and Food Technology. 2022;16(4):9-18.(in Persian)
54. Shi J, Cui J, Zheng T, Han X, Wang B, Wang W, et al. Comparative effects of aerobic and resistance exercise on bile acid profiles and liver function in patients with non-alcoholic fatty liver disease. BMC gastroenterology. 2025;25(1):239.
55. Fathi R, Nasiri K, Akbari A, Ahmadi-KaniGolzar F, Farajtabar Z. Exercise protects against ethanol-induced damage in rat heart and liver through the inhibition of apoptosis and activation of Nrf2/Keap-1/HO-1 pathway. Life Sciences. 2020;256:117958.
56. Sun M, Zhao X, Li X, Wang C, Lin L, Wang K, et al. Aerobic exercise ameliorates liver injury in Db/Db mice by attenuating oxidative stress, apoptosis and inflammation through the Nrf2 and JAK2/STAT3 signalling pathways. Journal of Inflammation Research. 2023;16:4805-19.
57. Takahashi H, Kotani K, Tanaka K, Egucih Y, Anzai K. Therapeutic approaches to nonalcoholic fatty liver disease: exercise intervention and related mechanisms. Frontiers in endocrinology. 2018;9:588.
58. Oh S, So R, Shida T, Matsuo T, Kim B, Akiyama K, et al. High-intensity aerobic exercise improves both hepatic fat content and stiffness in sedentary obese men with nonalcoholic fatty liver disease. Scientific reports. 2017;7(1):43029.
59. Jamka M, Makarewicz-Bukowska A, Bokayeva K, Śmidowicz A, Geltz J, Kokot M, et al. Comparison of the effect of endurance, strength and endurance-strength training on glucose and insulin homeostasis and the lipid profile of overweight and obese subjects: a systematic review and meta-analysis. International Journal of Environmental Research and Public Health.2022;19(22):14928.
60. Mirzaeyan E, Shirvani H. The Effect of High Intensity Interval Training on the Expression of Enolase3, Caveolin 3 Genes and Plasma Levels of SGOT Enzyme in the Cardiac Tissue of Male Rats with Fatty Liver (Steatosis). Yafteh. 2020;22(3):108-17.(in Persian)